Drawing for CELLEASE

USPTO serial 79339483

CELLEASE

Reviewed by CopyMark Law Group

Reg. 7357607Status 700Registered
Filing date
Status date
Registration date
Apr 16, 2024
Examiner
STADELI, MARTA ANN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CELLEASE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Douglas T. Johnson

Douglas T. Johnson Miller & Martin PLLC832 Georgia AvenueSuite 1200 Volunteer BuildingChattanooga, TN 37402-2289

Goods and services

ClassDescriptionStatusFirst use
005Medical reagents for use in rapid clinical, pharmaceutical and diagnostic testing for the analysis and testing of body fluids, namely, for measurement of in vitro coagulation and platelet function in bodily fluids, and for determining the presence of anticoagulants and platelet inhibitors in bodily fluidsACTIVE—
009Computer hardware, namely, desktop computers and handheld computers, detection devices being radiometers and adaptors for computers for connecting to a photometer for luminescence; downloadable and recorded software to be used in the field of rapid clinical and diagnostic testing for measurement of in vitro coagulation and platelet function in bodily fluids, and for determining the presence of anticoagulants and platelet inhibitors in bodily fluidsACTIVE—
010Medical testing apparatus, namely, microplates, cuvettes and disposable cartridges for use in rapid clinical and diagnostic testing for medical purposes, namely, for use in measurement of in vitro coagulation and platelet function in bodily fluids, and for determining the presence of anticoagulants and platelet inhibitors in bodily fluidsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 9, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 22, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 22, 2024FIMPFINAL DISPOSITION PROCESSED—
Jul 17, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 16, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Apr 16, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 30, 2024GPNXNOTIFICATION PROCESSED BY IB—
Jan 30, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 30, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 10, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 10, 2024OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jan 10, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 22, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 16, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 16, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 16, 2023ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Nov 11, 2023RDX3NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED—
Nov 11, 2023RDX1ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED—
Nov 11, 2023RRDXACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED—
Nov 10, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 9, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 9, 2023ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Oct 31, 2023OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Oct 11, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 11, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Aug 28, 2023GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Aug 28, 2023GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 28, 2023CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 25, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 24, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 24, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 21, 2023RFNTREFUSAL PROCESSED BY IB—
Jan 31, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 31, 2023RFRRREFUSAL PROCESSED BY MPU—
Dec 3, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 2, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 22, 2022DOCKASSIGNED TO EXAMINER—
Aug 13, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 17, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
May 12, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 10, 2022LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
May 5, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance